Log In
Print this Print this

IntelliGEN assay

  Manage Alerts
Collapse Summary General Information
Company Laboratory Corp. of America Holdings
DescriptionOncology panel that uses next generation squencing (NGS) platform
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetect somatic mutations in a panel of 50 cancer genes known to be involved in the development, progression and/or treatment of cancers
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today